Magazine Article | March 7, 2018

Pharma Cybersecurity After NotPetya

Source: Life Science Leader

By Gail Dutton, Contributing Writer
Follow Me On Twitter @GailLdutton

Last summer’s NotPetya ransomware attack should have been a wake-up call for the pharmaceutical industry. It infected organizations worldwide, including Merck. Employees at that pharmaceutical giant found manufacturing, research, sales, packaging, and formulations operations were locked. Even one month after the June 21 attack, some company operations were still recovering.

The magnitude of the attack jolted pharma executives, who began to understand the extent of the oncoming threats. Yet, rather than meaningfully enhancing cybersecurity, most resigned themselves to being hacked and turned their attention to driving innovation.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: